{"id":1223,"date":"2025-10-20T08:42:40","date_gmt":"2025-10-20T06:42:40","guid":{"rendered":"https:\/\/lensounds.com\/atoncohome\/"},"modified":"2026-03-31T13:38:36","modified_gmt":"2026-03-31T11:38:36","slug":"atoncohome","status":"publish","type":"page","link":"https:\/\/atonco-pharma.com\/en\/","title":{"rendered":"AtoncoHome"},"content":{"rendered":"<!--\nTitle: Atonco Hero \u2014 Alpha-immunotherapy\nSlug: atonco\/hero\nCategories: atonco\n-->\n\n\n\n<style>\n:root{\n  --ink:#0d2a3a;\n  --muted:#4c6678;\n  --primary:#3159da;\n  --primary-900:#2847b8;\n  --secondary:#3ae06a;\n  --card:#f0f4ff;\n  --bg:#ffffff;\n  --radius:18px;\n  --shadow-soft:0 10px 28px rgba(49,89,218,.14), 0 4px 14px rgba(13,42,58,.06);\n  --shadow-card:0 18px 52px rgba(49,89,218,.10), 0 6px 18px rgba(13,42,58,.08);\n  --atonco-border:#b9d0ff;\n}\n\n.atonco-hero,\n.atonco-hero * {\n  font-family: var(--wp--preset--font-family--montserrat);\n}\n\n.atonco-hero {\n  position: relative;\n  overflow: hidden;\n}\n\n.atonco-hero:before {\n  content: \"\";\n  position: absolute;\n  inset: 0;\n  background-image:\n    linear-gradient(to right, rgba(255,255,255,.05) 1px, transparent 1px),\n    linear-gradient(to bottom, rgba(255,255,255,.05) 1px, transparent 1px);\n  background-size: 36px 36px;\n  mask-image: linear-gradient(to bottom, black 20%, transparent 100%);\n  pointer-events: none;\n  z-index: 1;\n}\n\n.orb-wrap {\n  position: relative;\n  display: grid;\n  place-items: center;\n  padding: 40px 0;\n}\n\n.pill {\n  padding: 8px 18px;\n  border-radius: 999px;\n  border: 1.5px solid rgba(255,255,255,0.4);\n  background: rgba(49,89,218,0.3);\n  color: #ffffff;\n  font-weight: 600;\n  backdrop-filter: blur(10px);\n  display: inline-block;\n  margin: 6px 4px;\n  font-size: 0.9rem;\n}\n\n@media (max-width: 782px) {\n  .atonco-hero {\n    min-height: 100vh !important;\n    padding-top: 120px !important;\n    background-image: url('https:\/\/atonco-pharma.com\/wp-content\/uploads\/2025\/10\/video10.jpg') !important;\n    background-size: cover !important;\n    background-position: center !important;\n    background-repeat: no-repeat !important;\n  }\n\n  .atonco-hero img.wp-block-cover__image-background {\n    display: none !important;\n    visibility: hidden !important;\n    position: absolute !important;\n    width: 0 !important;\n    height: 0 !important;\n    opacity: 0 !important;\n  }\n\n  .atonco-hero .wp-block-cover__background {\n    position: absolute !important;\n    top: 0 !important;\n    left: 0 !important;\n    right: 0 !important;\n    bottom: 0 !important;\n  }\n\n  .orb {\n    width: min(280px, 85vw);\n  }\n\n  .stat-card-custom {\n    margin-bottom: 16px;\n  }\n}\n<\/style>\n\n\n\n\n<div class=\"wp-block-cover alignfull atonco-hero\" style=\"padding-top:100px;padding-right:2rem;padding-bottom:40px;padding-left:2rem;min-height:700px;aspect-ratio:unset;aspect-ratio:unset;\">\n  <span aria-hidden=\"true\" class=\"wp-block-cover__background has-black-background-color has-background-dim-30 has-background-dim\"><\/span>\n  <img decoding=\"async\" class=\"wp-block-cover__image-background\" alt=\"\" src=\"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2025\/10\/video10.jpg\" data-object-fit=\"cover\"\/>\n\n  <div class=\"wp-block-cover__inner-container is-layout-flow wp-block-cover-is-layout-flow\">\n    \n    <div class=\"wp-block-group has-global-padding is-layout-constrained wp-container-core-group-is-layout-84dd0e6d wp-block-group-is-layout-constrained\" style=\"padding-right:0;padding-left:0\">\n\n      \n      <div class=\"wp-block-columns are-vertically-aligned-center is-layout-flex wp-container-core-columns-is-layout-bce65f29 wp-block-columns-is-layout-flex\" style=\"margin-top:25px\">\n\n        \n        <div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:55%\">\n\n          \n          <p class=\"has-text-color\" style=\"color:#3ae06a;margin-bottom:0.9rem;font-size:0.78rem;font-weight:700;letter-spacing:0.12em;text-transform:uppercase\">Alpha-immunotherapy<\/p>\n          \n\n          \n          <h1 class=\"wp-block-heading has-text-color\" style=\"color:#ffffff;margin-bottom:0.9rem;font-size:clamp(2.1rem,2.2rem + 1.6vw,3.25rem);font-weight:800;letter-spacing:-0.02em;line-height:1.1\">Astatine against cancer<\/h1>\n          \n\n          \n          <div style=\"width:72px;height:3px;background:linear-gradient(90deg,#3159da,#ffffff 70%,transparent 100%);border-radius:4px;margin:10px 0 20px\"><\/div>\n          \n\n          \n          <p class=\"has-text-color\" style=\"color:#ffffff;margin-bottom:22px;font-size:1.08rem;background:rgba(255,255,255,0.2);padding:20px 24px;border-radius:16px;backdrop-filter:blur(10px);\">Developing a new generation of radiopharmaceuticals using astatine-211, an alpha-emitting radionuclide, to selectively destroy residual cancer cells.<\/p>\n          \n\n          \n          <div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n            \n            <div class=\"wp-block-button is-style-fill\">\n              <a class=\"wp-block-button__link has-text-color has-background wp-element-button\" style=\"border-radius:999px;color:#ffffff;background-color:#3159da;padding-top:10px;padding-right:18px;padding-bottom:10px;padding-left:18px\" href=\"https:\/\/atonco-pharma.com\/en\/about\/\">Atonco<\/a>\n            <\/div>\n            \n\n            \n            <div class=\"wp-block-button is-style-fill\">\n              <a class=\"wp-block-button__link has-text-color has-background wp-element-button\" style=\"border-radius:999px;color:#ffffff;background-color:#3159da;padding-top:10px;padding-right:18px;padding-bottom:10px;padding-left:18px\" href=\"https:\/\/atonco-pharma.com\/en\/technology\/\">Technology<\/a>\n            <\/div>\n            \n          <\/div>\n          \n\n        <\/div>\n        \n\n        \n        <div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:45%\">\n        <\/div>\n        \n\n      <\/div>\n      \n\n    <\/div>\n    \n  <\/div>\n<\/div>\n\n\n<!--\nTitle: Atonco Mission \u2014 Our mission\nSlug: atonco\/mission\nCategories: atonco\n-->\n\n\n<style>\n.mission-section-bg {\n  position: relative;\n  background:\n    radial-gradient(ellipse at 30% 0%, rgba(49,89,218,0.08) 0%, transparent 50%),\n    radial-gradient(ellipse at 70% 100%, rgba(58,224,106,0.06) 0%, transparent 50%),\n    linear-gradient(180deg, #ffffff 0%, #f8faff 50%, #f0f5ff 100%);\n}\n\n.mission-section-bg:before {\n  content: \"\";\n  position: absolute;\n  inset: 0;\n  background-image:\n    linear-gradient(to right, rgba(49,89,218,0.03) 1px, transparent 1px),\n    linear-gradient(to bottom, rgba(49,89,218,0.03) 1px, transparent 1px);\n  background-size: 50px 50px;\n  pointer-events: none;\n}\n\n.feature-item {\n  padding: 20px 0;\n  border-bottom: 1.5px solid rgba(185,208,255,0.5);\n  transition: all 0.3s ease;\n}\n\n.feature-item:last-child {\n  border-bottom: none;\n}\n\n.feature-item:hover {\n  padding-left: 12px;\n  border-left: 3px solid #3159da;\n  background: linear-gradient(90deg, rgba(49,89,218,0.05) 0%, transparent 100%);\n}\n\n.feature-item h4 {\n  margin: 0 0 8px;\n  color: #0d2a3a;\n  font-weight: 700;\n  font-size: 1.1rem;\n}\n\n.feature-item p {\n  margin: 0;\n  color: #4a5e91;\n  line-height: 1.6;\n}\n\n.impact-underline {\n  height: 3px;\n  background: linear-gradient(90deg, #3159da 0%, #414d93 35%, #3ae06a 70%, #3159da 100%);\n  width: 180px;\n  margin: 8px 0 32px;\n  border-radius: 2px;\n  box-shadow: 0 10px 30px rgba(0, 0, 0, .08);\n}\n<\/style>\n\n\n\n<div class=\"wp-block-group mission-section-bg has-global-padding is-layout-constrained wp-container-core-group-is-layout-13906c16 wp-block-group-is-layout-constrained\" style=\"padding-top:5rem;padding-right:2rem;padding-bottom:5rem;padding-left:2rem\">\n\n  <!-- HEADER -->\n  <div class=\"wp-block-group\" style=\"margin-bottom:48px\">\n\n    <div style=\"display:flex;align-items:center;gap:6px;color:#3159da;font-size:0.78rem;font-weight:700;letter-spacing:0.12em;text-transform:uppercase;width:fit-content;margin-bottom:0;\">\n      <span style=\"display:block;width:10px;height:10px;min-width:10px;min-height:10px;border-radius:50%;background:#3159da;box-shadow:0 0 0 3px rgba(49,89,218,0.2);flex:none;\"><\/span>\n      <span style=\"display:block;width:10px;height:10px;min-width:10px;min-height:10px;border-radius:50%;background:#3ae06a;box-shadow:0 0 0 3px rgba(58,224,106,0.2);flex:none;\"><\/span>\n      Atonco&#8217;s mission\n    <\/div>\n\n    \n    <div class=\"impact-underline\"><\/div>\n    \n\n    \n    <h2 class=\"wp-block-heading has-text-color\" style=\"color:#0d2a3a;margin-top:0.5rem;font-size:2.5rem;font-weight:800;letter-spacing:-0.01em;line-height:1.25\">Offering patients a longer life of better quality<\/h2>\n    \n\n  <\/div>\n\n  <!-- CONTENT GRID -->\n  \n  <div class=\"wp-block-columns are-vertically-aligned-center is-layout-flex wp-container-core-columns-is-layout-fa699a49 wp-block-columns-is-layout-flex\">\n\n    \n    <div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\">\n      \n      <div style=\"position:relative;padding-top:56.25%;border-radius:12px;overflow:hidden;box-shadow:0 10px 30px rgba(0,0,0,0.15);\">\n        <iframe src=\"https:\/\/player.mediadelivery.net\/embed\/533463\/e3be5fe9-878b-4d9d-a353-e7af55a76ac1\" loading=\"lazy\" style=\"border:none;position:absolute;top:0;left:0;height:100%;width:100%;\" allow=\"accelerometer;gyroscope;encrypted-media;picture-in-picture;\" allowfullscreen=\"true\"><\/iframe>\n      <\/div>\n      \n    <\/div>\n    \n\n    \n    <div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\">\n      \n      <div class=\"feature-item\">\n        <h4>Innovative therapy<\/h4>\n        <p>We are developing an antibody labeled with astatine-211 to destroy the last cancer cells left after conventional treatments.<\/p>\n      <\/div>\n      <div class=\"feature-item\">\n        <h4>Therapeutic precision<\/h4>\n        <p>Alpha particles emitted by astatine-211 with a very short range target the tumor and spare surrounding healthy tissues.<\/p>\n      <\/div>\n      <div class=\"feature-item\">\n        <h4>Operational excellence<\/h4>\n        <p>Atonco&#8217;s team is made up of an experienced team from the Nantes nuclear medicine cluster.<\/p>\n      <\/div>\n      \n    <\/div>\n    \n\n  <\/div>\n  \n\n  <!-- MISSION DESCRIPTION -->\n  \n  <p class=\"has-text-color\" style=\"color:#3f568a;margin-top:48px;font-size:1.05rem;line-height:1.8\">We develop innovative radiopharmaceutical products to destroy the last remaining cancer cells of residual disease left after conventional treatments. Our alpha-immunotherapy addresses clinical indications with genuine unmet therapeutic needs.<\/p>\n  \n\n<\/div>\n\n\n<!--\nTitle: Atonco Pipeline \u2014 Our technology\nSlug: atonco\/pipeline\nCategories: atonco\n-->\n\n\n<style>\n.sol-card-custom {\n  border-radius: 18px;\n  background: linear-gradient(135deg, rgba(49,89,218,.12), rgba(58,224,106,.10));\n  border: 1.6px solid #b9d0ff;\n  box-shadow: 0 10px 30px rgba(49,89,218,.10), 0 4px 12px rgba(58,224,106,.08);\n  padding: 22px;\n  height: 100%;\n}\n\n.sol-icon {\n  width: 44px;\n  height: 44px;\n  border-radius: 12px;\n  background: linear-gradient(135deg, #3159da, #3ae06a);\n  box-shadow: 0 8px 18px rgba(49,89,218,.35), inset 0 2px 6px rgba(255,255,255,.35);\n}\n\n.sol-card-custom h3 {\n  margin: 12px 0 6px;\n  color: #0d2a3a;\n  font-weight: 700;\n  font-size: 1.2rem;\n}\n\n.sol-card-custom p {\n  margin: 0 0 12px;\n  color: #2b4e60;\n  line-height: 1.6;\n}\n\n.sol-tags {\n  display: flex;\n  gap: 8px;\n  flex-wrap: wrap;\n}\n\n.tag {\n  font-weight: 700;\n  font-size: 0.82rem;\n  border-radius: 14px;\n  padding: 6px 10px;\n  border: 1.5px solid #b9d0ff;\n  background: #fff;\n  color: #116a8a;\n}\n\n@media (max-width: 782px) {\n  .sol-card-custom {\n    margin-bottom: 20px;\n  }\n  .pipeline-content-grid-mobile {\n    display: flex;\n    flex-direction: column;\n    gap: 24px;\n  }\n  .pipeline-cards-mobile {\n    display: flex;\n    flex-direction: column;\n    gap: 20px;\n  }\n}\n<\/style>\n\n\n\n<div class=\"wp-block-group has-white-background-color has-background has-global-padding is-layout-constrained wp-container-core-group-is-layout-13906c16 wp-block-group-is-layout-constrained\" style=\"padding-top:5rem;padding-right:2rem;padding-bottom:5rem;padding-left:2rem\">\n\n  <!-- HEADER -->\n  <div class=\"wp-block-group\" style=\"margin-bottom:48px\">\n\n    <div style=\"display:flex;align-items:center;gap:6px;color:#3159da;font-size:0.78rem;font-weight:700;letter-spacing:0.12em;text-transform:uppercase;width:fit-content;margin-bottom:0;\">\n      <span style=\"display:block;width:10px;height:10px;min-width:10px;min-height:10px;border-radius:50%;background:#3159da;box-shadow:0 0 0 3px rgba(49,89,218,0.2);flex:none;\"><\/span>\n      <span style=\"display:block;width:10px;height:10px;min-width:10px;min-height:10px;border-radius:50%;background:#3ae06a;box-shadow:0 0 0 3px rgba(58,224,106,0.2);flex:none;\"><\/span>\n      Our technology\n    <\/div>\n\n    \n    <div class=\"impact-underline\"><\/div>\n    \n\n    \n    <h2 class=\"wp-block-heading has-text-color\" style=\"color:#0d2a3a;font-size:2.5rem;font-weight:800;letter-spacing:-0.01em;line-height:1.25\">A highly promising disruptive innovation<\/h2>\n    \n\n  <\/div>\n\n  <!-- IMAGE + TEXT GRID -->\n  \n  <div class=\"wp-block-columns are-vertically-aligned-center pipeline-content-grid-mobile is-layout-flex wp-container-core-columns-is-layout-f9e1ab5d wp-block-columns-is-layout-flex\" style=\"margin-bottom:48px\">\n\n    \n    <div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\">\n      \n      <figure class=\"wp-block-image size-large has-custom-border\">\n        <img decoding=\"async\" src=\"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2025\/10\/research2.jpg\" alt=\"Clinical development pipeline\" style=\"border-radius:16px\"\/>\n      <\/figure>\n      \n    <\/div>\n    \n\n    \n    <div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\">\n\n      \n      <p class=\"has-text-color\" style=\"color:#4f5f92;margin-bottom:20px;font-size:1.15rem;font-weight:600\">Innovative targeted alpha radiotherapy programs to treat resistant cancers.<\/p>\n      \n\n      \n      <p class=\"has-text-color\" style=\"color:#3f568a;font-size:1.05rem;line-height:1.8\">The technology developed by Atonco is a highly promising disruptive innovation in the eradication of microscopic residual disease or isolated or clustered residual tumor cells that are rapidly accessible to a radiopharmaceutical labeled with astatine-211.<\/p>\n      \n\n    <\/div>\n    \n\n  <\/div>\n  \n\n  <!-- PIPELINE CARDS -->\n  \n  <div class=\"wp-block-columns pipeline-cards-mobile is-layout-flex wp-container-core-columns-is-layout-f709da35 wp-block-columns-is-layout-flex\">\n\n    \n    <div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n      \n      <div class=\"sol-card-custom\">\n        <div class=\"sol-icon\"><\/div>\n        <h3>ATO-101\u2122<\/h3>\n        <p>Girentuximab radiolabeled with astatine-211 for non-muscle-invasive bladder cancer (NMIBC) resistant to BCG.<\/p>\n        <div class=\"sol-tags\">\n          <span class=\"tag\">Phase 1<\/span>\n          <span class=\"tag\">NMIBC<\/span>\n          <span class=\"tag\">Anti-CAIX<\/span>\n        <\/div>\n      <\/div>\n      \n    <\/div>\n    \n\n    \n    <div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n      \n      <div class=\"sol-card-custom\">\n        <div class=\"sol-icon\"><\/div>\n        <h3>Clinical dose production<\/h3>\n        <p>Development and validation of the radiopharmaceutical production process in compliance with regulatory quality requirements.<\/p>\n        <div class=\"sol-tags\">\n          <span class=\"tag\">Astatine-211<\/span>\n          <span class=\"tag\">Quality<\/span>\n          <span class=\"tag\">Clinical<\/span>\n        <\/div>\n      <\/div>\n      \n    <\/div>\n    \n\n    \n    <div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n      \n      <div class=\"sol-card-custom\">\n        <div class=\"sol-icon\"><\/div>\n        <h3>Research &amp; Innovation<\/h3>\n        <p>Technological innovations protected by patents.<\/p>\n        <div class=\"sol-tags\">\n          <span class=\"tag\">R&amp;D<\/span>\n          <span class=\"tag\">Patents<\/span>\n          <span class=\"tag\">Innovation<\/span>\n        <\/div>\n      <\/div>\n      \n    <\/div>\n    \n\n  <\/div>\n  \n\n<\/div>\n\n\n<!--\nTitle: Atonco Stats \u2014 Bladder Cancer\nSlug: atonco\/stats\nCategories: atonco\n-->\n\n\n<style>\n.stat-card-custom {\n  background: #fff;\n  border-radius: 16px;\n  padding: 10px 24px;\n  border: 1.5px solid #b9d0ff;\n  box-shadow: 0 6px 20px rgba(49,89,218,.08);\n  text-align: center;\n  height: 100%;\n  display: flex;\n  flex-direction: column;\n  justify-content: center;\n  align-items: center;\n}\n\n.stat-number {\n  font-size: 2.8rem;\n  font-weight: 800;\n  color: #3159da;\n  margin: 0;\n  line-height: 1;\n}\n\n.stat-label {\n  font-size: 0.88rem;\n  color: #4a5e91;\n  font-weight: 600;\n  margin: 6px 0 0;\n  line-height: 1.3;\n}\n<\/style>\n\n\n\n<div class=\"wp-block-group has-white-background-color has-background has-global-padding is-layout-constrained wp-container-core-group-is-layout-974da196 wp-block-group-is-layout-constrained\" style=\"padding-top:4rem;padding-right:2rem;padding-bottom:5rem;padding-left:2rem\">\n\n  <div class=\"wp-block-group\" style=\"margin-bottom:48px\">\n\n    <div style=\"display:flex;align-items:center;gap:6px;color:#3159da;font-size:0.78rem;font-weight:700;letter-spacing:0.12em;text-transform:uppercase;width:fit-content;margin-bottom:0;\">\n      <span style=\"display:block;width:10px;height:10px;min-width:10px;min-height:10px;border-radius:50%;background:#3159da;box-shadow:0 0 0 3px rgba(49,89,218,0.2);flex:none;\"><\/span>\n      <span style=\"display:block;width:10px;height:10px;min-width:10px;min-height:10px;border-radius:50%;background:#3ae06a;box-shadow:0 0 0 3px rgba(58,224,106,0.2);flex:none;\"><\/span>\n      Medical impact\n    <\/div>\n\n    \n    <div class=\"impact-underline\"><\/div>\n    \n\n    \n    <h2 class=\"wp-block-heading has-text-color\" style=\"color:#0d2a3a;font-size:2.4rem;font-weight:800;line-height:1.25\">Bladder cancer: An unmet medical need<\/h2>\n    \n\n    \n    <p class=\"has-text-color\" style=\"color:#4f5f92;margin-top:8px;font-size:1.1rem\">A major therapeutic challenge requiring innovative approaches<\/p>\n    \n\n  <\/div>\n\n  <!-- STATS GRID -->\n  \n  <div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-ea2d2580 wp-block-columns-is-layout-flex\">\n    \n    <div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n      \n      <div class=\"stat-card-custom\">\n        <div class=\"stat-number\">614,000<\/div>\n        <div class=\"stat-label\">New cases per year<\/div>\n      <\/div>\n      \n    <\/div>\n    \n\n    \n    <div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n      \n      <div class=\"stat-card-custom\">\n        <div class=\"stat-number\">40%<\/div>\n        <div class=\"stat-label\">BCG failure rate<\/div>\n      <\/div>\n      \n    <\/div>\n    \n\n    \n    <div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n      \n      <div class=\"stat-card-custom\">\n        <div class=\"stat-number\">9th<\/div>\n        <div class=\"stat-label\">Most common cancer worldwide<\/div>\n      <\/div>\n      \n    <\/div>\n    \n  <\/div>\n  \n\n  <!-- CANCER CONTENT -->\n  <div class=\"wp-block-group\" style=\"margin-top:36px\">\n\n    \n    <p class=\"has-text-color\" style=\"color:#3f568a;margin-bottom:16px;font-size:1.05rem;line-height:1.7\">Bladder cancer is one of the most widespread malignant tumors in the world, with approximately 614,000 new cases diagnosed each year. It ranks 9th among the most common cancers and 6th among men.<\/p>\n    \n\n    \n    <p class=\"has-text-color\" style=\"color:#3f568a;font-size:1.05rem;line-height:1.7\">Despite current treatments, particularly BCG immunotherapy, approximately 40% of patients experience treatment failure, highlighting the urgent need for innovative therapeutic approaches such as the alpha-immunotherapy developed by Atonco.<\/p>\n    \n\n    \n    <p class=\"has-text-color\" style=\"color:#8a9bb5;margin-top:24px;font-size:0.8rem\">Source: <a href=\"https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/cancers\/30-bladder-fact-sheet.pdf\" target=\"_blank\" rel=\"noopener\">gco.iarc.who.int<\/a><\/p>\n    \n\n  <\/div>\n\n<\/div>\n\n\n<!--\nTitle: Atonco News \u2014 Latest news\nSlug: atonco\/news\nCategories: atonco\n-->\n\n\n<style>\n.news-section-bg {\n  background: #f6f9ff;\n}\n\n.news-item-custom {\n  padding-top: 14px;\n  border-top: 1.5px solid #b9d0ff;\n}\n\n.news-meta {\n  display: flex;\n  gap: 18px;\n  align-items: center;\n  margin-bottom: 14px;\n  color: #3159da;\n  font-weight: 700;\n  font-size: 0.92rem;\n}\n\n.news-title-item {\n  font-size: 1.2rem;\n  color: #0d2a3a;\n  font-weight: 800;\n  margin: 0 0 16px;\n  line-height: 1.3;\n}\n\n.news-link-custom {\n  font-weight: 800;\n  text-transform: uppercase;\n  font-size: 0.88rem;\n  text-decoration: none;\n  color: #3159da;\n  border-bottom: 2px solid #b9d0ff;\n  padding-bottom: 2px;\n  transition: opacity 0.2s;\n}\n\n.news-link-custom:hover {\n  opacity: 0.85;\n}\n\n.news-meta span:nth-child(2) {\n  display: none !important;\n}\n<\/style>\n\n\n\n<div class=\"wp-block-group news-section-bg has-global-padding is-layout-constrained wp-container-core-group-is-layout-13906c16 wp-block-group-is-layout-constrained\" style=\"padding-top:5rem;padding-right:2rem;padding-bottom:5rem;padding-left:2rem\">\n\n  <!-- HEADER -->\n  <div class=\"wp-block-group\" style=\"margin-bottom:48px\">\n\n    <div style=\"display:flex;align-items:center;gap:6px;color:#3159da;font-size:0.78rem;font-weight:700;letter-spacing:0.12em;text-transform:uppercase;width:fit-content;margin-bottom:0;\">\n      <span style=\"display:block;width:10px;height:10px;min-width:10px;min-height:10px;border-radius:50%;background:#3159da;box-shadow:0 0 0 3px rgba(49,89,218,0.2);flex:none;\"><\/span>\n      <span style=\"display:block;width:10px;height:10px;min-width:10px;min-height:10px;border-radius:50%;background:#3ae06a;box-shadow:0 0 0 3px rgba(58,224,106,0.2);flex:none;\"><\/span>\n      News\n    <\/div>\n\n    \n    <div class=\"impact-underline\"><\/div>\n    \n\n    \n    <h2 class=\"wp-block-heading has-text-color\" style=\"color:#0d2a3a;font-size:2.5rem;font-weight:800;letter-spacing:-0.01em;line-height:1.25\">Press release<\/h2>\n    \n\n    \n    <p class=\"has-text-color\" style=\"color:#4f5f92;margin-top:8px;font-size:1.15rem\"><\/p>\n    \n\n  <\/div>\n\n  <!-- NEWS GRID -->\n  <div class=\"wp-block-columns\" style=\"gap:36px;\">\n        <div class=\"wp-block-column\">\n            <article class=\"news-item-custom\">\n                <div class=\"news-meta\">\n                    <span>DECEMBER 2025<\/span>\n                    <span>ATONCO PRESS RELEASE<\/span>\n                <\/div>\n                <h3 class=\"news-title-item\">BLADDER CANCER: A FIRST IN FRANCE<\/h3>\n                <a class=\"news-link-custom\" href=\"https:\/\/atonco-pharma.com\/en\/2025\/12\/15\/bladder-cancer-a-first-in-france\/\">Lire<\/a>\n            <\/article>\n        <\/div>\n\n        \n        <div class=\"wp-block-column\">\n            <article class=\"news-item-custom\">\n                <div class=\"news-meta\">\n                    <span>NOVEMBER 2025<\/span>\n                    <span>ATONCO PRESS RELEASE<\/span>\n                <\/div>\n                <h3 class=\"news-title-item\">CLINICAL ALPHATHERAPY STATUS \u2013 NOVEMBER 2025<\/h3>\n                <a class=\"news-link-custom\" href=\"https:\/\/atonco-pharma.com\/en\/2025\/11\/20\/clinical-alphatherapy-november-2025\/\">Lire<\/a>\n            <\/article>\n        <\/div>\n\n        \n        <div class=\"wp-block-column\">\n            <article class=\"news-item-custom\">\n                <div class=\"news-meta\">\n                    <span>OCTOBER 2025<\/span>\n                    <span>ATONCO PRESS RELEASE<\/span>\n                <\/div>\n                <h3 class=\"news-title-item\">ATONCO ANNOUNCES THE APPOINTMENT OF DR. ALEXANDRA (GITEAU) PAILLARD AS CHIEF OPERATING OFFICER<\/h3>\n                <a class=\"news-link-custom\" href=\"https:\/\/atonco-pharma.com\/en\/2025\/10\/24\/atonco-announces-appointment-dr-alexandra-paillard-chief-operating-officer\/\">Lire<\/a>\n            <\/article>\n        <\/div>\n\n        <\/div>\n\n\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Offering patients a longer life of better quality Innovative therapy We are developing an antibody labeled with astatine-211 to destroy the last cancer cells left after conventional treatments. Therapeutic precision Alpha particles emitted by astatine-211 with a very short range target the tumor and spare surrounding healthy tissues. Operational excellence Atonco&#8217;s team is made up [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"pulsehome","meta":{"footnotes":""},"class_list":["post-1223","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Atonco \u2013 Alpha-Immunotherapy Against Bladder Cancer<\/title>\n<meta name=\"description\" content=\"Atonco develops ATO-101\u2122, an astatine-211 radiopharmaceutical for BCG-refractory non-muscle-invasive bladder cancer.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/atonco-pharma.com\/en\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Atonco \u2013 Alpha-Immunotherapy Against Bladder Cancer\" \/>\n<meta property=\"og:description\" content=\"Atonco develops ATO-101\u2122, an astatine-211 radiopharmaceutical for BCG-refractory non-muscle-invasive bladder cancer.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/atonco-pharma.com\/en\/\" \/>\n<meta property=\"og:site_name\" content=\"Atonco\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-31T11:38:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2025\/10\/video10.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/\",\"url\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/\",\"name\":\"Atonco \u2013 Alpha-Immunotherapy Against Bladder Cancer\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/atonco-pharma.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/video10.jpg\",\"datePublished\":\"2025-10-20T06:42:40+00:00\",\"dateModified\":\"2026-03-31T11:38:36+00:00\",\"description\":\"Atonco develops ATO-101\u2122, an astatine-211 radiopharmaceutical for BCG-refractory non-muscle-invasive bladder cancer.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#primaryimage\",\"url\":\"https:\\\/\\\/atonco-pharma.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/video10.jpg\",\"contentUrl\":\"https:\\\/\\\/atonco-pharma.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/video10.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AtoncoHome\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/\",\"name\":\"Atonco\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Atonco \u2013 Alpha-Immunotherapy Against Bladder Cancer","description":"Atonco develops ATO-101\u2122, an astatine-211 radiopharmaceutical for BCG-refractory non-muscle-invasive bladder cancer.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/atonco-pharma.com\/en\/","og_locale":"en_US","og_type":"article","og_title":"Atonco \u2013 Alpha-Immunotherapy Against Bladder Cancer","og_description":"Atonco develops ATO-101\u2122, an astatine-211 radiopharmaceutical for BCG-refractory non-muscle-invasive bladder cancer.","og_url":"https:\/\/atonco-pharma.com\/en\/","og_site_name":"Atonco","article_modified_time":"2026-03-31T11:38:36+00:00","og_image":[{"url":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2025\/10\/video10.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/atonco-pharma.com\/en\/","url":"https:\/\/atonco-pharma.com\/en\/","name":"Atonco \u2013 Alpha-Immunotherapy Against Bladder Cancer","isPartOf":{"@id":"https:\/\/atonco-pharma.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/atonco-pharma.com\/en\/#primaryimage"},"image":{"@id":"https:\/\/atonco-pharma.com\/en\/#primaryimage"},"thumbnailUrl":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2025\/10\/video10.jpg","datePublished":"2025-10-20T06:42:40+00:00","dateModified":"2026-03-31T11:38:36+00:00","description":"Atonco develops ATO-101\u2122, an astatine-211 radiopharmaceutical for BCG-refractory non-muscle-invasive bladder cancer.","breadcrumb":{"@id":"https:\/\/atonco-pharma.com\/en\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/atonco-pharma.com\/en\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/atonco-pharma.com\/en\/#primaryimage","url":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2025\/10\/video10.jpg","contentUrl":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2025\/10\/video10.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/atonco-pharma.com\/en\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/atonco-pharma.com\/en\/"},{"@type":"ListItem","position":2,"name":"AtoncoHome"}]},{"@type":"WebSite","@id":"https:\/\/atonco-pharma.com\/en\/#website","url":"https:\/\/atonco-pharma.com\/en\/","name":"Atonco","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/atonco-pharma.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/pages\/1223","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/comments?post=1223"}],"version-history":[{"count":9,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/pages\/1223\/revisions"}],"predecessor-version":[{"id":1335,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/pages\/1223\/revisions\/1335"}],"wp:attachment":[{"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/media?parent=1223"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}